We frequently update our articles to reflect the latest changes and updates to Medicare, and strongly recommend you visit this article at link below to confirm you have the latest version.
Printed Date: 9/22/2015
The following MolDX LCDs will be finalized on February 10, 2020:
MolDX has revised the Technical Assessment process. These changes are meant to streamline and clarify the process, reduce provider burden, and provide MolDX with pertinent test information necessary to make a coverage determination.
As part of this revision to the Technical Assessment (TA) process, MolDX requires TAs for all Targeted Next-Generation Sequencing (NGS) panels seeking coverage, including those seeking coverage with CPT codes 81445 and 81450. (Please see relevant definitions in our coverage Article: Targeted and Comprehensive Genomic Profile Next-Generation Sequencing Testing in Cancer (A54795)). This applies to all NGS tests, including new submissions and tests that are already covered.
Tests that have already undergone a formal TA and have had a dossier reviewed are considered complete and no further action is necessary. Tests that have not undergone such review are required to do so. The due date for TA submissions is February 10, 2020. If your lab chooses not to submit a TA by February 10, 2020, existing coverage will automatically end effective February 11, 2020.
Email email@example.com if you have already submitted a TA for a test.
Please access the TA checklist (PDF, 1 MB) and required forms on the MolDX website.
If you do not have NGS tests registered with MolDX, this email does not apply to you and no action is required.
We value your opinion and want to provide the highest-quality and most relevant Medicare knowledge possible. Please let us know if this article was helpful.
It didn't answer my question
This article was helpful
We’re glad we could help you today and appreciate your feedback. When you rate our articles as most helpful, we know that we are on the right track for providing you with important news and information.
We're sorry this article didn't help you today. We'll use your feedback to review this article try to revise or expand it. In the meantime we recommend you:
Last Updated: 12/26/2019
Applies to: MolDx
Article Topics: Appeals, Redeterminations, and PTANs